HealthEquity, Inc. $HQY Shares Acquired by Axiom Investors LLC DE

Axiom Investors LLC DE lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 11.1% during the 4th quarter, HoldingsChannel reports. The firm owned 168,216 shares of the company’s stock after purchasing an additional 16,819 shares during the quarter. Axiom Investors LLC DE’s holdings in HealthEquity were worth $15,410,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Capricorn Fund Managers Ltd acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $6,926,000. 12th Street Asset Management Company LLC boosted its holdings in shares of HealthEquity by 114.4% during the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock worth $25,784,000 after purchasing an additional 145,151 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of HealthEquity by 45.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock worth $14,741,000 after purchasing an additional 48,621 shares during the last quarter. King Luther Capital Management Corp boosted its holdings in shares of HealthEquity by 60.6% during the 3rd quarter. King Luther Capital Management Corp now owns 80,584 shares of the company’s stock worth $7,637,000 after purchasing an additional 30,394 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of HealthEquity by 11.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,205,077 shares of the company’s stock worth $114,205,000 after purchasing an additional 124,283 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HQY has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 18th. Barrington Research reaffirmed an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. Citizens Jmp lifted their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Finally, Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

HealthEquity Stock Up 1.6%

HQY stock opened at $89.23 on Wednesday. The firm has a market cap of $7.46 billion, a PE ratio of 33.42, a PEG ratio of 1.48 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The firm’s 50 day moving average price is $84.27 and its 200-day moving average price is $86.03. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $111.44.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president owned 91,141 shares of the company’s stock, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock valued at $1,193,000 over the last quarter. 1.60% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.